Blue Lake Biotechnology
Pre-clinicalBlue Lake is developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based system.
Founded
2018
Focus
Vaccines
About
Blue Lake is developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based system.
Funding History
2Total raised: $30M
Series A$25MFrazier Healthcare PartnersMar 15, 2022
Seed$5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2018
LocationDurham, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile